Oracle to buy drug software company Phase Forward
Posted by Reuters: Business News on April 16, 2010
NEW YORK (Reuters) – Software maker Oracle Corp is set to buy drug data management software company Phase Forward for about $685 million, aiming to bolster its health sciences business.
